ArticleFrontiers in immunology2025

Case Report: Bispecific CD20/CD30-targeted chimeric antigen receptor T-cell therapy for non-Hodgkin's lymphoma.

Yuejiao Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.